Article
Influence of CYP2C19 and ABCB1 Genetic Polymorphisms on Clopidogrel Pharmacokinetics: A PharmGKB Retrospective Analysis
2025-07-07
Abstract excerpt
<h4>Background: </h4> Clopidogrel, an antiplatelet prodrug widely prescribed for thrombotic risk reduction in cardiovascular patients, shows marked interindividual response variability due to genetic polymorphisms in CYP2C19 and ABCB1. <h4>Objectives:</h4> To determine the impact of key polymorphisms (CYP2C19 *2, *3 and ABCB1 3435C>T) on pharmacokinetic parameters and adherence outcomes, using curated PharmGKB...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 71d1265b-86ae-5ceb-af6e-aa9c75dad494
- DOI
- 10.20944/preprints202507.0576.v1
